"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. The meds you need, reliable and hassle free! Top products of top brands.The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe! |
| (new-moe-KAH-kuhl vaccine) |
| Pneumovax 23, Pnu-Imune 23 |
| Class: Vaccine, inactivated bacteria |
Action Induces antibodies against 23 capsular types of Streptococcus pneumoniae. Type-specific antibody facilitates bacterial destruction by complement-mediated lysis.
Indications Protection against pneumococcal pneumonia, pneumococcal bacteremia, and other pneumococcal infections.
Contraindications Patients with Hodgkin’s disease who have received extensive chemotherapy or nodal irradiation; patients with Hodgkin’s disease cannot have immunization < 10 days before or during chemotherapy; children < 2 yr. Some packages contain thimerosal as preservative; use cautiously in mercury-sensitive patients or choose different brand.
ADULTS & CHILDREN: SC/IM 0.5 ml. Booster dose: Revaccinate recipients of 14-valent pneumococcal vaccine (distributed from 1977 to 1983) who are also at highest risk of fatal pneumococcal infection (eg, asplenic patients), using 23-valent vaccine. Revaccinate adults who received 23-valent vaccine 6 or more yr earlier if they are also at highest risk or are likely to have rapid decline in antibody levels (eg, patients with asplenia, patients with nephrotic syndrome, renal failure or transplant recipients). Consider revaccination of children with nephrotic syndrome, asplenia or sickle-cell anemia after 3 to 5 yr, if these children would be < 10 yr of age at time of revaccination.
Interactions In patients anticipating immunosuppression, response to pneumococcal vaccine is best if administered 10 to 14 days prior to immunosuppressive chemotherapy or radiation. Pneumococcal and influenza vaccines and HIB, meningococcal and pneumococcal vaccines may safely and effectively be administered simultaneously at separate injection sites. As with other drugs administered by IM injection, give pneumococcal vaccine with caution to persons receiving anticoagulant therapy.
Lab Test Interferences None well documented.
Adverse Reactions Erythema and soreness at injection site, usually < 48 hr in duration. Local induration occurs less commonly. Rash, arthralgia, adenitis, fever > 39° C (102°F), malaise, myalgia and asthenia occur rarely. Low-grade fever (< 38.3°C or 100.9°F) occurs occasionally and usually subsides within 24 hr. Patients with otherwise stabilized immune thrombocytopenic purpura may rarely experience relapse in thrombocytopenia, 2 to 14 days after vaccination, lasting up to 2 wk. Anaphylactoid reactions have been rarely reported.
Pregnancy: Category C. Vaccinate if risk of disease outweighs risk to patients. Lactation: Undetermined.
| PATIENT CARE CONSIDERATIONS |
|
Popularity: 2% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply